What gets me is that she continued to work for the company after the alleged "abusive behavior and physical assault by Yan" that started in Oct. 2013 and she did not sue then!!!!
This study has been terminated.
(Portfolio prioritization due to slow enrollment)
any chance BCRX will participate in this:
The Government intends to have a full & open competition for this requirement in the form of a BAA. This synopsis is not a BAA; a BAA is anticipated on March 28, 2011. The Government expects to make 1 or more awards, subject to the availability of funds, on or about September 17, 2011. "
I see that but most often than not they say: "This study is not yet open for participant recruitment"
Any how we know that HHS is behind the study and this is good new.
Any body care to explain the study being active yet no study locations were given. Normally with a new study it says either recruiting or not recruiting yet.
"Results: 43 adults have been enrolled (target = 150 adults; 50 pediatrics); all with influenza A/H1N1. 17 required mechanical ventilation, 3 ECMO, and 5 renal replacement therapy during treatment. 79% had ³1 underlying chronic medical condition (35% respiratory, 25% immunosuppressive illness).
PK data are available for 39 subjects, with median (range) age at baseline = 46 yr (20‑78), body weight = 74 kg (43‑126), CLcr = 81 mL/min (13‑186). Vz (~23L) was independent of CLcr, as was Cmax from the initial 600mg dose. Consistent with Phase I experience, CL approximated CLcr; AUC and T½ increased accordingly with decreasing CLcr. Dosage adjustment for CLcr led to similar maintenance AUCs.
Grade ³3 adverse events (AEs) were reported in 13 subjects and serious AEs (SAE) in 9 (drug related or possibly related in 7 and 5 subjects, respectively). 4 of the SAEs were fatalities; none considered related to ZAN. ZAN Cmax and AUC were similar in subjects with drug-related AEs/SAEs relative to other patients with comparable CLcr"